Back to Search Start Over

Correlation between neutrophil gelatinase-associated lipocalin and soluble CD14 subtype on the prognosis evaluation of acute paraquat poisoning patients.

Authors :
Gao, X
Wang, W-Z
Xiao, Q-M
Qi, H-N
Zhu, B-Y
Li, B-Y
Wang, P
Han, Y-Y
Source :
Human & Experimental Toxicology; Apr2020, Vol. 39 Issue 4, p402-410, 9p, 2 Charts, 6 Graphs
Publication Year :
2020

Abstract

Objective: The objective of this article is to study the correlation between neutrophil gelatinase-associated lipocalin (NGAL) and soluble CD14 subtype (presepsin) on the severity and prognosis evaluation of acute paraquat poisoning (APP) patients. Materials and methods: We studied 120 APP patients who were divided into three groups: light (28 cases), moderate (52 cases), and heavy poisoning (40 cases) groups. Twenty healthy volunteers were enrolled as controls. Results: Acute kidney injury (AKI) occurred in 86 APP patients (71.7%, 86 of 120). In AKI group, urine NGAL was elevated 3 h after treatment, serum NGAL was elevated 24 h after treatment, and serum creatine (SCr) was elevated 2 days after treatment, which were all significantly higher than non-AKI group. Compared with control group, there were significant differences in presepsin and acute physiology and chronic health status (APACHE) II score of different poisoning groups. There were significant differences in detection indices 24 h, 3 days, and 7 days after treatment among different poisoning groups. There was a positive correlation between urine NGAL and serum paraquat concentration, urine NGAL, and AKI morbidity (r <subscript>1</subscript> = 0.974, r <subscript>2</subscript> = 0.766, p < 0.001), suggesting higher urine NGAL level indicated higher AKI morbidity. Receiver operating characteristic curves analysis suggested serum presepsin level and urine NGAL level had higher sensitivity and specificity than APACHE II score when predicting 28-day mortality of APP patients. Conclusion: Serum and urine NGAL level is elevated earlier than SCr, which is important for the early diagnosis of APP. Serum presepsin and urine NGAL levels can be used as markers to diagnose the severity of AKI and predict the mortality of APP patients. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09603271
Volume :
39
Issue :
4
Database :
Complementary Index
Journal :
Human & Experimental Toxicology
Publication Type :
Academic Journal
Accession number :
142555104
Full Text :
https://doi.org/10.1177/0960327119897111